Mass screening for breast cancer;Dépistage de masse du cancer du sein

Presse Medicale

Volumn 32, Issue 3, 2003, Pages 120-124

  Cottu, Paul Henri ^a   Cuvier, Caroline ^a   Perret, Francine ^a   Gorins, André ^a   Espié, Marc ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; FEMALE; FRANCE; GOVERNMENT; HEALTH CARE PERSONNEL; HUMAN; MAMMOGRAPHY;

EID: 18844481385     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Eifel P, Axelson JA, Costa J et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001; 93: 979-89.
2. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-27.
3. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. Jama 1995; 273: 149-54.
4. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988; 80: 1125-32.
5. Roberts MM, Alexander FE, Anderson TJ et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990; 335: 241-6.
6. Morrison AS, Brisson J, Khalid N. Breast cancer incidence and mortality in the breast cancer detection demonstration project [published erratum appears in J Natl Cancer Inst 1989; 81: 1513]. J Natl Cancer Inst 1988; 80: 1540-7.
7. Collette HJ, Day NE, Rombach JJ, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet 1984; 1: 1224-6.
8. Pad E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence District Programme. Int J Cancer 1990; 46: 198-202.
9. Peeters PH, Verbeek AL, Hendriks JH, Holland R, Mravunac M. The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme. Br J Cancer 1987; 56: 667-71.
10. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-8.
11. Tabar L, Fagerberg G, Chen HH et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995; 75(10): 2507-17.
12. Andersson I, Janzon L Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997; 22: 63-7.
13. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-9.
14. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Cmaj 1992; 147: 1459-76.
15. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Cmaj 1992; 147: 1477-88.
16. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995; 75: 997-1003.
17. Bjurstam N, Bjorneld L, Duffy SW et al. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. J Natl Cancer Inst Monogr 1997: 53-5.
18. Smart CR, Hendrick RE, Rutledge JH, 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995; 75: 1619-26.
19. Hendrick RE, Smith RA, Rutledge JH, 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997(22): 87-92.
20. Tabar L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA. A Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91: 1724-31.
21. Olsen O, Gotzsche PC. Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev 2001; 4: CD001877.
22. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-2.
23. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30: 187-210.
24. Andersson I, Aspegren K, Janzon L et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988; 297: 943-8.
25. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49-56.